Spots Global Cancer Trial Database for Empowering Patients' Lung Cancer Screening Uptake
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Empowering Patients' Lung Cancer Screening Uptake
Official Title: Empowering Patients' Lung Cancer Screening Uptake (Empower LCS)
Study ID: NCT06000683
Conditions
Study Description
Brief Summary: Lung cancer is the leading cause of cancer related mortality. Lung cancer screening (LCS) with low dose computed tomography (LDCT) decreases mortality rate of lung cancer by 20%. Yet many patients who are eligible for lung cancer screening are still falling through the cracks which prevents patients the ability to detect lung cancer early. This study will test the effect of a a multi-level intervention on ordering LDCT within 6 months after patient enrollment. Our proposed intervention includes (1) Primary care provider notifications of patients' LCS eligibility; (2) patients' education ; (3) patients' referral to financial navigation resources; and (4) patients' reminder to discuss LCS during PCP visit.
Detailed Description:
Keywords
Eligibility
Minimum Age: 50 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
UCI Health - Costa Mesa, Costa Mesa, California, United States
UCI Health Gottschalk Medical Plaza, Irvine, California, United States
UCI Health - Laguna Hills, Laguna Hills, California, United States
UCI Health - Newport Beach MacArthur, Newport Beach, California, United States
UCI Medical Center, Orange, California, United States
UCI Health - Tustin, Tustin, California, United States
UCI Health-Yorba Linda, Yorba Linda, California, United States
Contact Details
Name: Gelareh Sadigh, MD
Affiliation: University of California, Irvine
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
